Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

Drug repositioning is becoming more targeted and efficient with new technologies, offering personalized treatment options and growing interest in the field.

Personalized treatment with inhibitors, minoxidil, and laser therapy helps hair loss.

Personalized treatment plans are important for people with alopecia areata.

Persistent pulling on hair can cause permanent hair loss.

Personalized diets, like the Mediterranean Diet and low carb diets, can help manage PCOS symptoms in obese women, and probiotics may enhance weight loss and improve metabolic health. More research is needed to find the best diet strategies.

Long COVID in Japan involves persistent symptoms like fatigue and may be caused by lasting organ damage and prolonged inflammation, with vaccination as a potential treatment.

The summit concluded that new treatments like Jak inhibitors show promise for Alopecia Areata and personalized approaches are needed.

Many people suffer from hair loss, which is caused by a disruption in hair growth, and there is a need for personalized treatments and new drugs.

Personalized treatment plans combining natural and synthetic approaches are important for managing alopecia effectively.

Personalized thiopurine dosing based on NUDT15 genotyping can improve long-term outcomes for ulcerative colitis and Crohn's disease patients.

Person-to-person hair transplants can work for patients on lifelong immunosuppression, with high hair growth success.

Nociplastic type pain, common in Chronic Overlapping Pain Conditions, is a complex, heritable trait linked to 24 unique genetic factors and 127 genes, with potential shared mechanisms in cognitive, personality, and metabolic traits.

Linalool in personal care products may contribute to hair loss by damaging hair follicle stem cells and triggering harmful immune responses.

Personalized homeopathy medicine, along with lifestyle changes, can effectively treat Polycystic Ovarian Syndrome.

Astringent persimmon fruit extract may help increase hair length and coverage without increasing the number of hair follicles.

Personalized treatment based on detailed tumor analysis successfully managed and reduced the patient's aggressive hair follicle cancer.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Large data can lead to new medical discoveries and personalized medicine.

Accurate diagnosis and personalized treatment are crucial for managing women's hair loss.

The article suggests renaming Polycystic Ovarian Syndrome (PCOS) to "Hyperandrogenic Persistent Ovulatory Dysfunction Syndrome" (HA-PODS) for accuracy and consistency, but no final decision was made.

A person with a specific gene mutation had extra teeth, unique jaw and hair features not seen before in this condition.

A person with Turner Syndrome showed severe schizophrenia that didn't respond to treatment and had brain shrinkage.

A person was born with both a rare hairless condition and a type of birthmark, which is an uncommon combination.

A person with thyroid problems had rare, swollen, bald spots on their scalp caused by a condition usually found on the shins.

A person with Werner syndrome was initially thought to just have female pattern hair loss.

More personalized and effective treatments for androgenetic alopecia are needed.

A person got uncombable hair syndrome from two copies of chromosome 1 from their mother.

A person had two different benign skin tumors, a trichoadenoma and melanocytic naevi, at the same time but in different places on the face.

A person with a new mutation in the SCN1A gene developed brain inflammation after COVID-19.